Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
Issue Archive
> October 2007 Issue of MMM
October 2007 42 10 Issue of MMM
Editor's Desk
The pursuit of persistence
To say that tackling patient compliance and persistence poses a challenge to the pharmaceutical industry is like calling Tiger Woods a competent golfer or describing ...
Features
Biotech Blurring
Big pharma has long looked to biotechs to help fatten pipelines, but one company has experienced the benefits of keeping things in-house. Matthew Arnold looks ...
Insight Exchange: Point of Care
Several distinguished experts from pharmaceutical marketing and media descend on the offices of MM&M to discuss the evolution, effectiveness and measurement of point-of-care communications. James ...
The Chain Gang
AstraZeneca's Arimidex Web site features the innovative use of social media wherein patients actually become part of the product marketing while simultaneously forging a relationship ...
Tough Losses
Medical/surgical journals ad spend declines by 5% and continues on its downward trend. PERQ/HCI's Eugene M. May reports on the numbers for the first half ...
Headliner: Frank Burroughs of Abigail's Alliance
Frank Burroughs is the soul of patience—and persistence.
Antidote
Antidote
I never believed it was entirely fair that Eli Lilly was the target of vicious attacks regarding its anti-psychotic drug, Zyprexa.
In Focus
Med ed ruling creates chaos for CME units
In a medical-education ruling expected to have broad consequences, regulators said they will consider advertising agencies and journal publishers as commercial entities, requiring those that ...
Med Ed Report
New CEO: SEC was warm-up for ACCME
As John Connolly settles into his new post as president & CEO of M|C Communications, he may find certain experiences from his past especially useful.
Advocacy groups set to meet with Senate staff members
CME advocates will take a targeted set of talking points with them this fall to meetings with representatives on Capitol Hill.
Alta Communications purchases HMP Communications
Private equity firm Alta Communications bought HMP Communications from BG Media Investors.
Grassley and Kohl introduce legislation
Sens. Chuck Grassley (R-IA) and Herb Kohl (D-WI) introduced legislation that would require drug and device manufacturers to disclose to HHS anything of value given ...
Heffernan promoted to director, AMA accreditation
Kevin Heffernan was promoted to the position of director, American Medical Association accreditation and CPPD educational activities.
Professional Media
Elsevier launches an oncology portal
Elsevier is upping the ante for online medical publishing with an advertising-supported Web site for physicians using content from most of its more than 100 ...
JAMA reclaims top spot despite losses
The Journal of the American Medical Association reclaimed its place as the top medical/surgical journal by ad revenue.
The British Medical Journal hires Nature's Ashman
The British Medical Journal poached Nature Publishing Group’s Peter Ashman to serve as its publishing director.
Nature Publishing Group's cardio title now accepting original research
Nature Publishing Group says its cardiovascular specialty title will now accept original research.
Canon Communications acquired Engel Publishing Partners
Canon Communications, a subsidiary of Apprise Media, acquired Med Ad News and PharmaLive publisher Engel Publishing Partners from Euromoney Institutional Investor.
Urology Times wins two Azbee Awards
Advanstar's Urology Times won two Azbee Awards from the American Society of Business Publication Editors.
Media Forum
Explaining the DTC-NME disconnect
With annual approvals for NMEs at their lowest point in a decade, one would think pharma would launch fewer ad campaigns.
E-marketing
Web Watch
Internet advertising revenues reached a new high of $4.9 million in the first quarter of 2007.
Novartis contest seeks user-generated content
Marketers from Novartis Vaccines and Diagnostics have jumped into the user-generated content arena with a contest that invites Web-savvy filmmakers to submit their work and ...
More women go online for health info
Women are more likely than men to search the Web for health information, according to a survey conducted by researchers from Smithfield, RI's Bryant University.
Direct Marketing
Wunderman adds new role to its shop
Wunderman has hired Ira Haimowitz for the newly created role of group director, datastrategy.
GSK's Avandia woes spark talk of cuts
UK drugmaker GlaxoSmithKline is eyeing cuts to its sales force in response to declining sales of its type 2 diabetes drug Avandia.
Eisai, Salix team up to push Colazal
Salix Pharmaceuticals and Eisai have entered into a multi-year co-promotion deal to promote Salix's ulcerative colitis treatement Colazal (balsalazide disodium).
Mary Ann Kim joins MediZine
Mary Ann Kim has joined MediZine as senior marketing manager, brand services from AWE, an entertainment marketing agency under Omnicom, where she was responsible for ...
CBI hosts Pharmaceutical Direct to Physician Sales and Marketing Summit
The Center for Business Intelligence will host the Pharmaceutical Direct to Physician Sales and Marketing Summit on Oct. 24-25 to discuss how marketers can leverage ...
HealthEd hires Jennifer Kirchherr
HealthEd has hired Jennifer Kirchherr as senior account executive, supporting interactive media development of tailored patient education programs.
Dudnyk gets certified to implement is Closed Loop Marketing software
Dudnyk was certified by Proscape Technologies to implement its Closed Loop Marketing software for tablet PC-based programs.
DTC Report
FDA studying TV ads for distractions
The FDA is planning to launch a study into whether positive, upbeat or relaxing images appearing in DTC TV ads may also distract viewers from ...
Lab dives into DTC with awareness ads
Myriad Genetics, a Salt Lake City diagnostics firm which offers testing for genetic susceptibility to breast and ovarian cancer, is launching a northeast regional advertising ...
TNS, Cymfony release white paper
TNS Media Intelligence/Cymfony released a white paper on social media monitoring and marketing designed to help companies delve into social media like blogs, podcasts, social ...
NEJM reports that DTC spend increased 330% between '96-'05
In a critical Aug. 16 article on the impact of DTC advertising, The New England Journal of Medicine reported that spending on DTC pharmaceutical advertising ...
Center for American Progress calls for pre-1985 moratorium on DTC
Liberal think tank the Center for American Progress called for the restoration of the pre-1985 moratorium on DTC advertising to require the same disclosures of ...
Sugarman-Brozan says FDA is neglecting enforcement
Prescription Access Litigation project director Alex Sugarman-Brozan told the Third Annual FDA Regulatory Symposium at Harvard in August that the agency is neglecting to enforce ...
Public Relations
PR View by John Seng
The word transparency resonates with communications professionals, accountants, auditors and marketers alike.
AMA, ACS hit Washington on insurance crusade
With advocacy groups pouring millions into advertising and PR aimed at influencing the national debate on health insurance, it must be a presidential election cycle.
Ketchum shuffles its London practice
Ketchum reorganized its London management, naming former European healthcare head Avril Lee as co-deputy CEO, responsible for the office's three main consultancy offers in healthcare, ...
Marketing Research
Vantage Point
I've heard a lot of chatter recently about whether pharma companies are spending less on marketing research than in previous years.
TNS: 'Common currency' can help compare tactics
Having trouble comparing blogs, text messages or word-of-mouth to other forms of communication modes in terms of how they influence your brand?
Rx data firms sue Maine, Vermont
Three firms are challenging Maine and Vermont over new state laws that restrict the collection and disclosure of physician prescribing information.
Washington Insider
As I see it
Many were waiting to see if and when the new FDA commissioner would make a significant difference in the agency's defensive, stonewalling posture.
DoD sharing its medical safety data with FDA
Data from the US Military Health System related to the review and use of FDA-regulated drugs, biologics and medical devices will be shared with the ...
FDA wins experimental drugs decision
The Washington, DC Court of Appeals has ruled in the FDA's favor that terminally ill patients have no "fundamental right 'deeply rooted in this nation's ...
Abbott nixes info on Web, group claims
Abbott employees have edited over 1,000 online Wikipedia entries involving some of the company's drug products in an attempt to change or remove unfavorable safety ...
Researchers view a weaker DDMAC
A 10-year review of DTC advertising by researchers from three major universities suggests that oversight of advertising by the FDA’s DDMAC has declined dramatically.
FDA says Geodon journal ad omits risk info
The FDA says a professional journal ad for Pfizer's antipsychotic medication Geodon (ziprasidone mesylate) for injection omits important risk info and contains unsubstantiated superiority claims.
File card for Exelon makes unsubstantiated superiority claims
A professional file card for Novartis' Exelon makes unsubstantiated superiority claims, overstates the drug's efficacy.
BMS revises hepatitis B therapy warning label
The FDA reports that Bristol-Myers Squibb has revised hepatitis B therapy Baraclude's boxed warning labeling to caution against its use in HIV/hepatitis B virus co-infected ...
Supplemental NDA for stronger version of Advair deemed "not approvable"
A GlaxoSmithKline supplemental NDA for a stronger version of asthma drug Advair Diskus for use in treating patients with chronic obstructive pulmonary disease, recommended for ...
Back Talk
In search of perfect pitch
In baseball, a pitch that was perfect in Abner Doubleday's era would still be pretty darn good today--the dimensions of the strike zone have stayed ...
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Pharmas are from Mars, Payers are from Venus
No-see docs are know-nothings when it comes to new drug info, study suggests
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Coach vs. cancer in BMS-backed awareness effort
Harvard urges faculty to ditch journals
Study: Young Latinas are key decision makers, prefer English
Pharma Report 2012: Get Back in Shape
Massachusetts gift ban under attack (again)
Pfizer, Crestor tops for global promotional spend in 2011
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Med Ed Report: Show Me the Money
No-see docs are know-nothings when it comes to new drug info, study suggests
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Mobile
Sales Force